Author Correction: PRMT1 Promotes Pancreatic Cancer Growth and Predicts Poor Prognosis

Cellular Oncology - Germany
doi 10.1007/s13402-019-00480-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2016English

Interleukin-33 Predicts Poor Prognosis and Promotes Ovarian Cancer Cell Growth and Metastasis Through Regulating ERK and JNK Signaling Pathways

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2015English

ERO1α Promotes Hypoxic Tumor Progression and Is Associated With Poor Prognosis in Pancreatic Cancer

Oncotarget
Oncology
2019English

Downregulation of miR‑505 Promotes Cell Proliferation, Migration and Invasion, and Predicts Poor Prognosis in Breast Cancer

Oncology Letters
Cancer ResearchOncology
2019English

High Hepsin Expression Predicts Poor Prognosis in Gastric Cancer

Scientific Reports
Multidisciplinary
2016English

Jumonji Domain-Containing Protein 1A Promotes Cell Growth and Progression via Transactivation of C-Myc Expression and Predicts a Poor Prognosis in Cervical Cancer

Oncotarget
Oncology
2016English

Long Non‑coding RNA XIST Predicts Poor Prognosis and Promotes Malignant Phenotypes in Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2018English

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance

PLoS ONE
Multidisciplinary
2018English

HOXA13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients With Esophageal Squamous Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy